Clinical Trial Update: Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

View source ↗

Summary

Completion notice for NCT07155382 describing allogeneic hematopoietic cell transplantation using BuFluATG conditioning (busulfan, fludarabine, anti-thymocyte gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED